Prostatic Neoplasms trials recruiting in California

All Prostatic Neoplasms trials nationally

Cities in California

Recruiting trials in California

• 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
  NCT06706921 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
  NCT06925737 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: Duarte, Irvine, La Jolla, Long Beach
• A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT07719361 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• A Study of DM002 in Patients With Advanced Solid Tumors
  NCT06751329 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
  NCT06136650 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Irvine, Los Angeles, Orange, Palo Alto
• Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
  NCT06056830 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: Los Angeles, Orange, Stanford
• Prostate Active Surveillance Study
  NCT00756665 · Phase: Not specified · Ages: 21 Years and older · Sex: Male · California: San Francisco, Stanford